Abstract:γ-aminobutyric acid type A receptors (GABAARs) are the major mediators of synaptic inhibition in the brain. Aberrant GABAAR activity or regulation is observed in various neurodevelopmental disorders, neurodegenerative diseases and mental illnesses, including epilepsy, Alzheimer's and schizophrenia. Benzodiazepines, anesthetics and other pharmaceutics targeting these receptors find broad clinical use, but their inherent lack of receptor subtype specificity causes unavoidable side effects, raising a need for new or adjuvant medications. In this review article, we introduce a new strategy to modulate GABAeric signaling: targeting the intracellular protein interactors of GABAARs. Of special interest are scaffolding, anchoring and supporting proteins that display high GABAAR subtype specificity. Recent efforts to target gephyrin, the major intracellular integrator of GABAergic signaling, confirm that GABAAR-associated proteins can be successfully targeted through diverse molecules, including recombinant proteins, intrabodies, peptide-based probes and small molecules. Small-molecule artemisinins and peptides derived from endogenous interactors, that specifically target the universal receptor binding site of gephyrin, acutely affect synaptic GABAAR numbers and clustering, modifying neuronal transmission. Interference with GABAAR trafficking provides another way to modulate inhibitory signaling. Peptides blocking the binding site of GABAAR to AP2 increase the surface concentration of GABAAR clusters and enhance GABAergic signaling. Engineering of gephyrin binding peptides delivered superior means to interrogate neuronal structure and function. Fluorescent peptides, designed from gephyrin binders, enable live neuronal staining and visualization of gephyrin in the post synaptic sites with submicron resolution. We anticipate that in the future, novel fluorescent probes, with improved size and binding efficiency, may find wide application in super resolution microscopy studies, enlightening the nanoscale architecture of the inhibitory synapse. Broader studies on GABAAR accessory proteins and the identification of the exact molecular binding interfaces and affinities will advance the development of novel GABAAR modulators and following in vivo studies will reveal their clinical potential as adjuvant or stand-alone drugs.

Identification of GABA(C) receptor protein homeostasis network components from three tandem mass spectrometry proteomics approaches

Translational Patterns of Ionotropic Glutamate and GABA Receptors During Brain Development and Behavioral Stimuli Revealed by Polysome Profiling

Remodeling the endoplasmic reticulum proteostasis network restores proteostasis of pathogenic GABAA receptors

Glutamate and GABA A receptor crosstalk mediates homeostatic regulation of neuronal excitation in the mammalian brain

Proteostasis Regulators Restore Function of Epilepsy-Associated GABAA Receptors

Grp94 Protein Delivers γ-Aminobutyric Acid Type A (GABAA) Receptors to Hrd1 Protein-mediated Endoplasmic Reticulum-associated Degradation

Hsp47 promotes biogenesis of multi-subunit neuroreceptors in the endoplasmic reticulum

Targeting GABAAR-Associated Proteins: New Modulators, Labels and Concepts

Cryo-EM structures of inactive and active GABA B receptor

Stable High Expression of Human Gamma-Aminobutyric Acida Receptors Composed of Alpha and Beta Subünits

Control of cell surface expression of GABAA receptors by a conserved region at the end of the N-terminal extracellular domain of receptor subunits

Heteromeric GABA<sub>A</sub>receptor structures in positively-modulated active states

Gaba(B) Receptor Activation Protects Neurons From Apoptosis Via Igf-1 Receptor Transactivation

Modular Structure and Polymerization Status of GABAA Receptors Illustrated with EM Analysis and AlphaFold2 Prediction

Glutamate and Γ-Aminobutyric Acid Receptors and Their Characteristics in Retina

Pharmacological activation of ATF6 remodels the proteostasis network to rescue pathogenic GABAA receptors

Homeostatic plasticity of GABAergic synaptic transmission in mice lacking GAT1.

Heteromeric GABAA receptor structures in positively-modulated active states

Structural Basis of GABARAP-mediated GABAA Receptor Trafficking and Functions on GABAergic Synaptic Transmission

GABA promotes interstitial fluid clearance in an AQP4-dependent manner by activating the GABAA R

GABA Promotes Interstitial Fluid Clearance in an AQP4-dependent Manner by Activating the GABAAR